Sign up for the exclusive GALAXY clinical alert service and be the first to know the latest results from the GALAXY clinical studies programme. As a subscriber you will receive an e-mail as soon as new data from the GALAXY programme is published giving you firsthand exclusive access to clinical study information.
The rosuvastatin GALAXY programme is addressing unanswered questions in statin research by investigating links between optimal lipid control, atherosclerosis and cardiovascular morbidity and mortality.
Please register in order to receive the GALAXY Clinical Alert service or to download free copies of study publications. As guaranteed by our privacy policy, your email address will not be used to send unsolicited messages.
